C反応性タンパク質検査の市場規模、シェア、動向分析レポート：アッセイタイプ別、検出範囲別、疾患領域別、最終用途別、地域別、セグメント別予測、2025年～2030年

C反応性タンパク質検査市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界のC反応性タンパク質（CRP）検査市場規模は2030年までに56億6,000万米ドルに達すると予測され、2025～2030年のCAGRは0.24％で成長すると予測されています。

C反応性タンパク質検査の成長は、検査の様々な応用を探求することを目的とした重要な研究活動に起因しています。こうした調査活動は、このセグメントの研究を促進するための資金を提供する民間と公的機関の存在によってさらに促進されています。ナノテクノロジーツールの進歩により、市場は著しい成長を遂げると予想されます。これらの進歩は、高い特異性、感度、迅速な応答時間、医療現場での正確な疾患診断とモニタリングのための多重化能力などの特性を持つポータブル生物分析アッセイを開発する有望な機会を記載しています。

これらの進歩は、予測期間中にCRP検査の需要を促進すると予想されます。さらに、戦略的取引や開発の増加、研究開発への投資の増加が成長を促進しています。CRPは感染や炎症の重症度を評価する重要なバイオマーカーと考えられているため、COVID-19の大流行は市場にかなりの影響を与えています。その結果、サービスや製品に対する需要が高まっています。アボット社などの主要企業は、SARS-CoV-2感染に特化したCRP検査用の支援ツールを提供しており、市場成長にさらに貢献しています。さらに、主要企業は製品の発売やポイントオブケアCRP検査の開発に注力するようになり、これが今後数年間の市場の成長をさらに促進すると予測されています。

例えば、2022年7月、ブルーム・ダイアグノスティックスは、血液中のCRPレベルを定量化するために設計された半自動検査キットであるブルーム炎症検査を発表しました。このシングルユースのキットは、体内の炎症の検出に役立ちます。市場の成長は、検査施設の設立によってさらに刺激されると予想されます。2021年6月、Trivitron医療はCOVID-19診断用の移動式検査室を発表し、農村部、都市部、遠隔地を含むインドの様々な地域での検査サービスを可能にしました。この固有の検査室は、CRP、IL-6、D-ダイマーなどの炎症マーカーのCLIA/Elisa検査、迅速抗原検査、RT-PCR検査、CLIA/Elisa抗体検査IgMとIgGなど、さまざまな検査を提供しています。

北米は2022年に39.42%の最大収益シェアを占め、心血管疾患の有病率の増加、着実な製品発売、既存市場参入企業の存在、技術進歩、整備された医療インフラにより、予測期間中もそのシェアを維持すると予測されます。アジア太平洋は、2023～2030年にかけて最も速いCAGR 0.49％で成長すると予測されています。COVID-19パンデミックは中国発祥です。感染の重症度を判定する潜在的なバイオマーカーであるCRP検査の需要は、間もなく増加すると予想されます。世界の産業で事業を展開する主要企業は、その存在感を維持するため、製品の発売と地理的拡大に絶えず注力しています。

C反応性タンパク質検査市場レポートハイライト

• アッセイタイプ別では、免疫比濁アッセイセグメントが2024年に48.5%の最大収益シェアを占めました。サンプル中のCRPレベルを正確に検出するための広い測定範囲を提供する、高感度、自動化された、費用対効果の高い免疫比濁アッセイの導入による。
• 検出範囲別では、2024年にはhs-CRPセグメントが約42.80%の収益シェアで市場を独占しました。hs-CRPは従来型CRPに比べて検出範囲が広いのが特徴です。
• 疾患領域別では、心血管疾患セグメントが2024年に最大の市場シェアを占め、予測期間を通じて市場を独占すると予想されます。CVDの有病率の増加がCRP検査市場の成長に寄与する主要因です。
• 特にCOVID-19のパンデミックに対応して病院でのCRP検査の採用が増加したため、病院のエンドユーザーセグメントが2024年の市場シェア28.0%で優位を占めました。これにより検査率が高まり、同セグメントの成長に寄与しています。
• さらに、慢性心疾患やがんの有病率の増加により、市場は成長を遂げています。これらの疾患の診断、管理、モニタリングにおけるCRP検査の需要が高まっているため、これらの疾患は市場の拡大に大きく寄与しています。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 C反応性タンパク質検査市場の変数、動向、範囲

• 市場イントロダクション/系統展望
• 市場規模と成長展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• C反応性タンパク質検査市場分析ツール
  • ポーターのファイブフォース分析
  • PESTEL分析

第4章 C反応性タンパク質検査市場：アッセイタイプ別、推定・動向分析

• C反応性タンパク質検査市場：アッセイタイプ変動分析
• 免疫比濁測定アッセイ
  • 免疫比濁測定アッセイ市場、2018～2030年
• ELISA
  • ELISA市場、2018～2030年
  • 臨床ELISA
  • 非臨床ELISA
• 化学発光免疫測定
  • 化学発光免疫測定市場、2018～2030年
• その他
  • その他市場、2018～2030年

第5章 C反応性タンパク質検査市場：検出範囲別、推定・動向分析

• C反応性タンパク質検査市場：検出範囲変動分析
• 高感度C反応性タンパク質（hs-CRP）
  • 高感度C反応性タンパク質（hs-CRP）市場、2018～2030年
• 従来型CRP
  • 従来型CRP市場、2018～2030年
• 心臓CRP（cCRP）
  • 心臓CRP（cCRP）市場、2018～2030年

第6章 C反応性タンパク質検査市場：疾患領域別、推定・動向分析

• C反応性タンパク質検査市場：疾患領域変動分析
• 心血管疾患
  • 心血管疾患市場、2018～2030年
• がん
  • がん市場、2018～2030年
• 関節リウマチ
  • 関節リウマチ市場、2018～2030年
• 炎症性腸疾患
  • 炎症性腸疾患市場、2018～2030年
• 子宮内膜症
  • 子宮内膜症市場、2018～2030年
• ループス
  • ループス市場、2018～2030年
• その他
  • その他市場、2018～2030年

第7章 C反応性タンパク質検査市場：最終用途別、推定・動向分析

• C反応性タンパク質検査市場：最終用途変動分析
• クリニック
  • クリニック市場、2018～2030年
  • クリニック、団体別
  • クリニック、環境別
• 病院
  • 病院市場、2018～2030年
  • 都市環境
  • 地方環境
• ラボ
  • ラボ市場、2018～2030年
  • 都市環境
  • 地方環境
• 介護付き医療施設
  • 介護付き医療施設市場、2018～2030年
  • 都市環境
  • 地方環境
• 住宅
  • 住宅市場、2018～2030年
• その他
  • その他市場、2018～2030年

第8章 C反応性タンパク質検査市場：地域別、推定・動向分析

• C反応性タンパク質検査市場シェア（地域別、2024年と2030年、100万米ドル）
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 主要市場参入企業による最近の動向と影響分析
• 企業分類
• 企業ヒートマップ分析
• 企業プロファイル
• Abbott
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Siemens Healthineers AG
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Danaher Corporation
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Quest Diagnostics
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Siemens Healthineers AG
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Abbott
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Merck KGaAA
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Zoetis
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• F. Hoffmann-La Roche AG
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Ortho Clinical Diagnostics
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Thermo Fisher Scientific, Inc.
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• HORIBA, Ltd
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Randox Laboratories Ltd.
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Boditech Med, Inc.
  • 参入企業概要
  • 最近の動向/戦略的取り組み
• Aidian
  • 参入企業概要
  • 最近の動向/戦略的取り組み

List of Tables

• Table 1 List of abbreviation
• Table 2 Global C-reactive protein market, by region, 2018 - 2030 (USD Million)
• Table 3 Global C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 4 Global C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 5 Global C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 6 Global C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 7 North America C-reactive protein market, by country, 2018 - 2030 (USD Million)
• Table 8 North America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 9 North America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 10 North America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 11 North America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 12 U.S. C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 13 U.S. C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 14 U.S. C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 15 U.S. C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 16 Canada C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 17 Canada C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 18 Canada C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 19 Canada C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 20 Mexico C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 21 Mexico C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 22 Mexico C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 23 Mexico C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 24 Europe C-reactive protein market, by country, 2018 - 2030 (USD Million)
• Table 25 Europe C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 26 Europe C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 27 Europe C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 28 Europe C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 29 UK C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 30 UK C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 31 UK C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 32 UK C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 33 Germany C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 34 Germany C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 35 Germany C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 36 Germany C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 37 France C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 38 France C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 39 France C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 40 France C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 41 Italy C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 42 Italy C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 43 Italy C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 44 Italy C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 45 Spain C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 46 Spain C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 47 Spain C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 48 Spain C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 49 Denmark C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 50 Denmark C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 51 Denmark C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 52 Denmark C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 53 Sweden C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 54 Sweden C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 55 Sweden C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 56 Sweden C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 57 Norway C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 58 Norway C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 59 Norway C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 60 Norway C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 61 Asia Pacific C-reactive protein market, by country, 2018 - 2030 (USD Million)
• Table 62 Asia Pacific C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 63 Asia Pacific C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 64 Asia Pacific C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 65 Asia Pacific C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 66 Japan C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 67 Japan C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 68 Japan C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 69 Japan C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 70 China C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 71 China C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 72 China C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 73 China C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 74 India C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 75 India C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 76 India C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 77 India C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 78 Australia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 79 Australia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 80 Australia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 81 Australia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 82 South Korea C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 83 South Korea C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 84 South Korea C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 85 South Korea C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 86 Thailand C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 87 Thailand C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 88 Thailand C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 89 Thailand C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 90 Latin America C-reactive protein market, by country, 2018 - 2030 (USD Million)
• Table 91 Latin America C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 92 Latin America C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 93 Latin America C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 94 Latin America C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 95 Brazil C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 96 Brazil C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 97 Brazil C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 98 Brazil C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 99 Argentina C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 100 Argentina C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 101 Argentina C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 102 Argentina C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 103 MEA C-reactive protein market, by country, 2018 - 2030 (USD Million)
• Table 104 MEA C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 105 MEA C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 106 MEA C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 107 MEA C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 108 South Africa C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 109 South Africa C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 110 South Africa C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 111 South Africa C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 112 Saudi Arabia C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 113 Saudi Arabia C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 114 Saudi Arabia C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 115 Saudi Arabia C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 116 UAE C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 117 UAE C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 118 UAE C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 119 UAE C-reactive protein market, by end-use, 2018 - 2030 (USD Million)
• Table 120 Kuwait C-reactive protein market, by assay type, 2018 - 2030 (USD Million)
• Table 121 Kuwait C-reactive protein market, by disease type, 2018 - 2030 (USD Million)
• Table 122 Kuwait C-reactive protein market, by detection range, 2018 - 2030 (USD Million)
• Table 123 Kuwait C-reactive protein market, by end-use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 C-reactive protein testing market segmentation
• Fig. 2 Data analysis models
• Fig. 3 Market formulation and validation
• Fig. 4 Data validating & publishing
• Fig. 5 Market research process
• Fig. 6 Information procurement
• Fig. 7 Primary research
• Fig. 8 Value-chain-based sizing & forecasting
• Fig. 9 QFD modelling for market share assessment
• Fig. 10 Market formulation & validation
• Fig. 11 Commodity flow analysis
• Fig. 12 Market outlook
• Fig. 13 Segment snapshot-1
• Fig. 14 Segment snapshot-2
• Fig. 15 Competitive landscape snapshot
• Fig. 16 Market trends & outlook
• Fig. 17 Porter's five force analysis
• Fig. 18 PESTEL analysis
• Fig. 19 C-reactive protein testing market: Assay type outlook key takeaways
• Fig. 20 C-reactive protein testing market: Assay type movement analysis
• Fig. 21 Immunoturbidimetric assay market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 22 ELISA market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 23 Chemiluminescence Immunoassay (CLIA ) market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 24 Other Reagents & Kits market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 25 C-reactive protein market: Detection Range outlook key takeaways
• Fig. 26 C-reactive protein market: Detection Range movement analysis
• Fig. 27 hs-CRP market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 28 Conventional CRP market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 29 cCRP market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 30 C-reactive protein market: Disease Type outlook key takeaways
• Fig. 31 C-reactive protein market: Disease Type movement analysis
• Fig. 32 Cardiovascular diseases market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 33 Cancer market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 34 Rheumatoid arthritis market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 35 Inflammatory bowel disease Testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 36 Endometriosis market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 37 Lupus market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 38 Others market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 39 C-reactive protein market: End-use outlook key takeaways
• Fig. 40 C-reactive protein market: End-use movement analysis
• Fig. 41 Hospitals market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 42 Clinics market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 43 Physician Office clinics market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 44 Small clinics market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 45 Others clinics market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 46 Laboratories market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 47 Assisted living healthcare facilities market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 48 Home market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 49 Others market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 50 Regional marketplace outlook, 2024 & 2030 (USD million)
• Fig. 51 Regional marketplace: Key takeaways
• Fig. 52 North America C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 53 Key country dynamics
• Fig. 54 U.S. C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 55 Key country dynamics
• Fig. 56 Canada C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 57 Key country dynamics
• Fig. 58 Mexico C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 59 Europe C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 60 Key country dynamics
• Fig. 61 UK C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 62 Key country dynamics
• Fig. 63 Germany C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 64 Key country dynamics
• Fig. 65 France C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 66 Key country dynamics
• Fig. 67 Spain C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 68 Key country dynamics
• Fig. 69 Italy C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 70 Key country dynamics
• Fig. 71 Denmark C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 72 Key country dynamics
• Fig. 73 Sweden C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 74 Key country dynamics
• Fig. 75 Norway C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 76 Asia Pacific C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 77 Key country dynamics
• Fig. 78 Japan C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 79 Key country dynamics
• Fig. 80 China C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 81 Key country dynamics
• Fig. 82 India C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 83 Key country dynamics
• Fig. 84 Australia C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 85 Key country dynamics
• Fig. 86 South Korea C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 87 Key country dynamics
• Fig. 88 Thailand C-reactive protein testing market estimates and forecasts, 2018 - 2030 (USD million)
• Fig. 89 Key country dynamics
• Fig. 90 Market participant categorization
• Fig. 91 C-reactive protein testing market position analysis, 2023
• Fig. 92 Strategic framework

C-Reactive Protein Testing Market Growth & Trends:

The global C-reactive protein testing market size is expected to reach USD 5.66 billion by 2030 and is projected to grow at a CAGR of 0.24% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growth of C-reactive protein (CRP) testing can be attributed to significant research activities aimed at exploring various applications of testing. These research efforts are further facilitated by the presence of both private and public agencies that provide funding to expedite research in this field. The market is anticipated to witness significant growth owing to advancements in nanotechnological tools. These advancements offer promising opportunities to develop portable bioanalytical assays that possess attributes, such as high specificity, sensitivity, rapid response time, and the ability to perform multiplexing for accurate disease diagnosis and monitoring at the point of care.

These advancements are expected to drive the demand for CRP testing during the forecast period. Furthermore, an increase in strategic deals and developments, as well as higher investments in research and development has fueled the growth. The COVID-19 pandemic has had a considerable impact on the market, as CRP is considered a crucial biomarker for assessing the severity of infection and inflammation. As a result, there is an increased demand for services and products. Leading companies, such as Abbott, provide supportive tools for CRP testing specifically for SARS-CoV-2 infection, further contributing to market growth. Moreover, key players increased focus on product launches and developments in point-of-care CRP tests, which is projected to further fuel the market's growth in the coming years.

For instance, in July 2022, Bloom Diagnostics introduced the Bloom Inflammation Test, a semi-automated testing kit designed for the quantification of CRP levels in the blood. This single-use kit aids in the detection of inflammation within the body. The growth of the marketplace is expected to be further stimulated by the establishment of testing facilities. In June 2021, Trivitron Healthcare unveiled a mobile laboratory for COVID-19 diagnostics, enabling testing services in various regions of India, including rural, urban, and remote areas. This indigenous laboratory offers a range of tests, including CLIA/Elisa tests for inflammatory markers, such as a CRP, IL-6, and D-Dimer, as well as rapid antigen tests, RT-PCR tests, CLIA/Elisa Antibodies Tests IgM and IgG, and others.

North America held the largest revenue share of 39.42% in 2022 and is expected to maintain its share during the forecast period due to the increasing prevalence of cardiovascular diseases, a steady stream of product launches, presence of established market players, technological advancements, and well-developed healthcare infrastructure. Asia Pacific is projected to grow at the fastest CAGR of 0.49% from 2023 to 2030. The COVID-19 pandemic originated in China. Being the potential biomarker for determining the severity of the infection, the demand for CRP testing is expected to increase shortly. Key players operating in the global industry are constantly focusing on product launches and geographical expansion to maintain their presence.

C-Reactive Protein Testing Market Report Highlights:

• Based on assay type, the immunoturbidimetric assay segment held the largest revenue share of 48.5% in 2024. Owing to the introduction of a highly sensitive, automated, and cost-effective immunoturbidimetric assay that offers a wide measuring range for accurately detecting the levels of CRP in samples
• Based on detection ranges, the hs-CRP segment dominated the market in 2024 with a revenue share of approximately 42.80%. The hs-CRP features a broad detection range than that compared to the conventional CRP
• Based on disease area type, the cardiovascular diseases segment dominated the market with the largest market share in 2024 and is anticipated to dominate the market throughout the forecast period. The increase in the prevalence of CVDs is the major factor contributing to the growth of the CRP testing market
• The hospitals end-user segment dominated with a market share of 28.0% in 2024 due to the increased adoption of CRP testing in hospitals, particularly in response to the COVID-19 pandemic. This has led to a higher testing rate and contributed to the segment's growth
• Furthermore, the marketplace is experiencing growth due to the increasing prevalence of chronic heart diseases and cancers. These conditions contribute significantly to the market's expansion as there is a rising demand for CRP testing in the diagnosis, management, and monitoring of these diseases

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Market Definitions
  • 1.2.1. Assay Type
  • 1.2.2. Detection Range
  • 1.2.3. Disease Type
  • 1.2.4. End Use
• 1.3. Research Methodology
  • 1.3.1. Information Procurement
  • 1.3.2. Information or Data Analysis
  • 1.3.3. Market Formulation & Data Visualization
  • 1.3.4. Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. C-Reactive Protein Testing Market Variables, Trends, & Scope

• 3.1. Market Introduction/Lineage Outlook
• 3.2. Market Size and Growth Prospects (USD Million)
• 3.3. Market Dynamics
  • 3.3.1. Market Drivers Analysis
    • 3.3.1.1. Rising incidence of chronic and infectious diseases
    • 3.3.1.2. Increasing demand for point-of-care diagnostics
    • 3.3.1.3. Growing demand for portable and automated C-reactive proteins
  • 3.3.2. Market Restraints Analysis
    • 3.3.2.1. Lower detection limit
    • 3.3.2.2. Limitations associated with C-reactive protein techniques
• 3.4. C-Reactive Protein Testing Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
    • 3.4.1.1. Bargaining power of the suppliers
    • 3.4.1.2. Bargaining power of the buyers
    • 3.4.1.3. Threats of substitution
    • 3.4.1.4. Threats from new entrants
    • 3.4.1.5. Competitive rivalry
  • 3.4.2. PESTEL Analysis
    • 3.4.2.1. Political landscape
    • 3.4.2.2. Economic and Social landscape
    • 3.4.2.3. Technological landscape
    • 3.4.2.4. Environmental landscape
    • 3.4.2.5. Legal landscape

Chapter 4. C-Reactive Protein Testing Market: Assay Type Estimates & Trend Analysis

• 4.1. C-reactive Protein (CRP) Testing Market: Assay Type Movement Analysis
• 4.2. Immunoturbidimetric Assay
  • 4.2.1. Immunoturbidimetric Assay Market, 2018 - 2030 (USD Million)
• 4.3. ELISA
  • 4.3.1. ELISA Market, 2018 - 2030 (USD Million)
  • 4.3.2. Clinical ELISA
    • 4.3.2.1. Clinical ELISA Market, 2018 - 2030 (USD Million)
  • 4.3.3. Nonclinical ELISA
    • 4.3.3.1. Nonclinical ELISA Market, 2018 - 2030 (USD Million)
• 4.4. Chemiluminescence Immunoassay
  • 4.4.1. Chemiluminescence Immunoassay Market, 2018 - 2030 (USD Million)
• 4.5. Others
  • 4.5.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. C-Reactive Protein Testing Market: Detection Range Estimates & Trend Analysis

• 5.1. C-reactive Protein (CRP) Testing Market: Detection Range Movement Analysis
• 5.2. High Sensitivity C-reactive Protein (hs-CRP)
  • 5.2.1. High Sensitivity C-reactive Protein (hs-CRP) Market, 2018 - 2030 (USD Million)
• 5.3. Conventional CRP
  • 5.3.1. Conventional CRP Market, 2018 - 2030 (USD Million)
• 5.4. Cardiac CRP (cCRP)
  • 5.4.1. Cardiac CRP (CCRP) Market, 2018 - 2030 (USD Million)

Chapter 6. C-Reactive Protein Testing Market Disease Area Estimates & Trend Analysis

• 6.1. C-reactive Protein (CRP) Testing Market: Disease Area Movement Analysis
• 6.2. Cardiovascular Diseases
  • 6.2.1. Cardiovascular Diseases Market, 2018 - 2030 (USD Million)
• 6.3. Cancer
  • 6.3.1. Cancer Market, 2018 - 2030 (USD Million)
• 6.4. Rheumatoid Arthritis
  • 6.4.1. Rheumatoid Arthritis Market, 2018 - 2030 (USD Million)
• 6.5. Inflammatory Bowel Disease
  • 6.5.1. Inflammatory Bowel Disease Market, 2018 - 2030 (USD Million)
• 6.6. Endometriosis
  • 6.6.1. Endometriosis Market, 2018 - 2030 (USD Million)
• 6.7. Lupus
  • 6.7.1. Lupus Market, 2018 - 2030 (USD Million)
• 6.8. Others
  • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. C-Reactive Protein Testing Market End Use Estimates & Trend Analysis

• 7.1. C-reactive Protein (CRP) Testing Market: End-use Movement Analysis
• 7.2. Clinics
  • 7.2.1. Clinics Market, 2018 - 2030 (USD Million)
  • 7.2.2. Clinics, by entity
    • 7.2.2.1. Physician offices
      • 7.2.2.1.1. Physician Offices Market, 2018 - 2030 (USD Million)
    • 7.2.2.2. Small clinics
      • 7.2.2.2.1. Small Clinics Market, 2018 - 2030 (USD Million)
    • 7.2.2.3. Others
      • 7.2.2.3.1. Others Market, 2018 - 2030 (USD Million)
  • 7.2.3. Clinics, by setting
    • 7.2.3.1. Urban setting
      • 7.2.3.1.1. Urban Setting Market, 2018 - 2030 (USD Million)
    • 7.2.3.2. Rural settings
      • 7.2.3.2.1. Rural Settings Market, 2018 - 2030 (USD Million)
• 7.3. Hospitals
  • 7.3.1. Hospitals Market, 2018 - 2030 (USD Million)
  • 7.3.2. Urban setting
    • 7.3.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
  • 7.3.3. Rural settings
    • 7.3.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
• 7.4. Laboratories
  • 7.4.1. Laboratories Market, 2018 - 2030 (USD Million)
  • 7.4.2. Urban setting
    • 7.4.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
  • 7.4.3. Rural settings
    • 7.4.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
• 7.5. Assisted Living Healthcare Facilities
  • 7.5.1. Assisted Living Healthcare Facilities Market, 2018 - 2030 (USD Million)
  • 7.5.2. Urban setting
    • 7.5.2.1. Urban Setting Market, 2018 - 2030 (USD Million)
  • 7.5.3. Rural settings
    • 7.5.3.1. Rural Settings Market, 2018 - 2030 (USD Million)
• 7.6. Home
  • 7.6.1. Home Market, 2018 - 2030 (USD Million)
• 7.7. Others
  • 7.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 8. C-Reactive Protein Testing Market: Regional Estimates & Trend Analysis

• 8.1. C-Reactive Protein Testing Market Share, By Region, 2024 & 2030, USD Million
• 8.2. North America
  • 8.2.1. North America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.2. U.S.
    • 8.2.2.1. Key Country Dynamics
    • 8.2.2.2. Target Disease Prevalence
    • 8.2.2.3. Competitive Scenario
    • 8.2.2.4. Regulatory Framework
    • 8.2.2.5. Reimbursement Scenario
    • 8.2.2.6. U.S. C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.3. Canada
    • 8.2.3.1. Key Country Dynamics
    • 8.2.3.2. Target Disease Prevalence
    • 8.2.3.3. Competitive Scenario
    • 8.2.3.4. Regulatory Framework
    • 8.2.3.5. Reimbursement Scenario
    • 8.2.3.6. Canada C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.2.4. Mexico
    • 8.2.4.1. Key Country Dynamics
    • 8.2.4.2. Target Disease Prevalence
    • 8.2.4.3. Competitive Scenario
    • 8.2.4.4. Regulatory Framework
    • 8.2.4.5. Reimbursement Scenario
    • 8.2.4.6. Mexico C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.3. Europe
  • 8.3.1. Europe C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.2. UK
    • 8.3.2.1. Key Country Dynamics
    • 8.3.2.2. Target Disease Prevalence
    • 8.3.2.3. Competitive Scenario
    • 8.3.2.4. Regulatory Framework
    • 8.3.2.5. Reimbursement Scenario
    • 8.3.2.6. UK C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.3. Germany
    • 8.3.3.1. Key Country Dynamics
    • 8.3.3.2. Target Disease Prevalence
    • 8.3.3.3. Competitive Scenario
    • 8.3.3.4. Regulatory Framework
    • 8.3.3.5. Reimbursement Scenario
    • 8.3.3.6. Germany C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.4. France
    • 8.3.4.1. Key Country Dynamics
    • 8.3.4.2. Target Disease Prevalence
    • 8.3.4.3. Competitive Scenario
    • 8.3.4.4. Regulatory Framework
    • 8.3.4.5. Reimbursement Scenario
    • 8.3.4.6. France C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.5. Italy
    • 8.3.5.1. Key Country Dynamics
    • 8.3.5.2. Target Disease Prevalence
    • 8.3.5.3. Competitive Scenario
    • 8.3.5.4. Regulatory Framework
    • 8.3.5.5. Reimbursement Scenario
    • 8.3.5.6. Italy C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.6. Spain
    • 8.3.6.1. Key Country Dynamics
    • 8.3.6.2. Target Disease Prevalence
    • 8.3.6.3. Competitive Scenario
    • 8.3.6.4. Regulatory Framework
    • 8.3.6.5. Reimbursement Scenario
    • 8.3.6.6. Spain C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.7. Denmark
    • 8.3.7.1. Key Country Dynamics
    • 8.3.7.2. Target Disease Prevalence
    • 8.3.7.3. Competitive Scenario
    • 8.3.7.4. Regulatory Framework
    • 8.3.7.5. Reimbursement Scenario
    • 8.3.7.6. Denmark C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.8. Sweden
    • 8.3.8.1. Key Country Dynamics
    • 8.3.8.2. Target Disease Prevalence
    • 8.3.8.3. Competitive Scenario
    • 8.3.8.4. Regulatory Framework
    • 8.3.8.5. Reimbursement Scenario
    • 8.3.8.6. Sweden C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.3.9. Norway
    • 8.3.9.1. Key Country Dynamics
    • 8.3.9.2. Target Disease Prevalence
    • 8.3.9.3. Competitive Scenario
    • 8.3.9.4. Regulatory Framework
    • 8.3.9.5. Reimbursement Scenario
    • 8.3.9.6. Norway C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.4. Asia Pacific
  • 8.4.1. Asia Pacific C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.2. Japan
    • 8.4.2.1. Key Country Dynamics
    • 8.4.2.2. Target Disease Prevalence
    • 8.4.2.3. Competitive Scenario
    • 8.4.2.4. Regulatory Framework
    • 8.4.2.5. Reimbursement Scenario
    • 8.4.2.6. Japan C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.3. China
    • 8.4.3.1. Key Country Dynamics
    • 8.4.3.2. Target Disease Prevalence
    • 8.4.3.3. Competitive Scenario
    • 8.4.3.4. Regulatory Framework
    • 8.4.3.5. Reimbursement Scenario
    • 8.4.3.6. China C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.4. India
    • 8.4.4.1. Key Country Dynamics
    • 8.4.4.2. Target Disease Prevalence
    • 8.4.4.3. Competitive Scenario
    • 8.4.4.4. Regulatory Framework
    • 8.4.4.5. Reimbursement Scenario
    • 8.4.4.6. India C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.5. Australia
    • 8.4.5.1. Key Country Dynamics
    • 8.4.5.2. Target Disease Prevalence
    • 8.4.5.3. Competitive Scenario
    • 8.4.5.4. Regulatory Framework
    • 8.4.5.5. Reimbursement Scenario
    • 8.4.5.6. Australia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.6. South Korea
    • 8.4.6.1. Key Country Dynamics
    • 8.4.6.2. Target Disease Prevalence
    • 8.4.6.3. Competitive Scenario
    • 8.4.6.4. Regulatory Framework
    • 8.4.6.5. Reimbursement Scenario
    • 8.4.6.6. South Korea C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.4.7. Thailand
    • 8.4.7.1. Key Country Dynamics
    • 8.4.7.2. Target Disease Prevalence
    • 8.4.7.3. Competitive Scenario
    • 8.4.7.4. Regulatory Framework
    • 8.4.7.5. Reimbursement Scenario
    • 8.4.7.6. Thailand C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.5. Latin America
  • 8.5.1. Latin America C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.2. Brazil
    • 8.5.2.1. Key Country Dynamics
    • 8.5.2.2. Target Disease Prevalence
    • 8.5.2.3. Competitive Scenario
    • 8.5.2.4. Regulatory Framework
    • 8.5.2.5. Reimbursement Scenario
    • 8.5.2.6. Brazil C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.5.3. Argentina
    • 8.5.3.1. Key Country Dynamics
    • 8.5.3.2. Target Disease Prevalence
    • 8.5.3.3. Competitive Scenario
    • 8.5.3.4. Regulatory Framework
    • 8.5.3.5. Reimbursement Scenario
    • 8.5.3.6. Argentina C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 8.6. Middle East and Africa
  • 8.6.1. Middle East and Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.2. South Africa
    • 8.6.2.1. Key Country Dynamics
    • 8.6.2.2. Target Disease Prevalence
    • 8.6.2.3. Competitive Scenario
    • 8.6.2.4. Regulatory Framework
    • 8.6.2.5. Reimbursement Scenario
    • 8.6.2.6. South Africa C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.3. Saudi Arabia
    • 8.6.3.1. Key Country Dynamics
    • 8.6.3.2. Target Disease Prevalence
    • 8.6.3.3. Competitive Scenario
    • 8.6.3.4. Regulatory Framework
    • 8.6.3.5. Reimbursement Scenario
    • 8.6.3.6. Saudi Arabia C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.4. UAE
    • 8.6.4.1. Key Country Dynamics
    • 8.6.4.2. Target Disease Prevalence
    • 8.6.4.3. Competitive Scenario
    • 8.6.4.4. Regulatory Framework
    • 8.6.4.5. Reimbursement Scenario
    • 8.6.4.6. UAE C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 8.6.5. Kuwait
    • 8.6.5.1. Key Country Dynamics
    • 8.6.5.2. Target Disease Prevalence
    • 8.6.5.3. Competitive Scenario
    • 8.6.5.4. Regulatory Framework
    • 8.6.5.5. Reimbursement Scenario
    • 8.6.5.6. Kuwait C-Reactive Protein Testing Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Recent Developments & Impact Analysis by Key Market Participants
• 9.2. Company Categorization
• 9.3. Company Heat Map Analysis
• 9.4. Company Profiles
• 9.5. Abbott
  • 9.5.1. Participant's Overview
  • 9.5.2. Financial Performance
  • 9.5.3. Product Benchmarking
  • 9.5.4. Recent Developments/ Strategic Initiatives
• 9.6. Siemens Healthineers AG
  • 9.6.1. Participant's Overview
  • 9.6.2. Financial Performance
  • 9.6.3. Product Benchmarking
  • 9.6.4. Recent Developments/ Strategic Initiatives
• 9.7. Danaher Corporation
  • 9.7.1. Participant's Overview
  • 9.7.2. Financial Performance
  • 9.7.3. Product Benchmarking
  • 9.7.4. Recent Developments/ Strategic Initiatives
• 9.8. Quest Diagnostics
  • 9.8.1. Participant's Overview
  • 9.8.2. Financial Performance
  • 9.8.3. Product Benchmarking
  • 9.8.4. Recent Developments/ Strategic Initiatives
• 9.9. Siemens Healthineers AG
  • 9.9.1. Participant's Overview
  • 9.9.2. Financial Performance
  • 9.9.3. Product Benchmarking
  • 9.9.4. Recent Developments/ Strategic Initiatives
• 9.10. Abbott
  • 9.10.1. Participant's Overview
  • 9.10.2. Financial Performance
  • 9.10.3. Product Benchmarking
  • 9.10.4. Recent Developments/ Strategic Initiatives
• 9.11. Merck KGaAA
  • 9.11.1. Participant's Overview
  • 9.11.2. Financial Performance
  • 9.11.3. Product Benchmarking
  • 9.11.4. Recent Developments/ Strategic Initiatives
• 9.12. Zoetis
  • 9.12.1. Participant's Overview
  • 9.12.2. Financial Performance
  • 9.12.3. Product Benchmarking
  • 9.12.4. Recent Developments/ Strategic Initiatives
• 9.13. F. Hoffmann-La Roche AG
  • 9.13.1. Participant's Overview
  • 9.13.2. Financial Performance
  • 9.13.3. Product Benchmarking
  • 9.13.4. Recent Developments/ Strategic Initiatives
• 9.14. Ortho Clinical Diagnostics
  • 9.14.1. Participant's Overview
  • 9.14.2. Financial Performance
  • 9.14.3. Product Benchmarking
  • 9.14.4. Recent Developments/ Strategic Initiatives
• 9.15. Thermo Fisher Scientific, Inc.
  • 9.15.1. Participant's Overview
  • 9.15.2. Financial Performance
  • 9.15.3. Product Benchmarking
  • 9.15.4. Recent Developments/ Strategic Initiatives
• 9.16. HORIBA, Ltd
  • 9.16.1. Participant's Overview
  • 9.16.2. Financial Performance
  • 9.16.3. Product Benchmarking
  • 9.16.4. Recent Developments/ Strategic Initiatives
• 9.17. Randox Laboratories Ltd.
  • 9.17.1. Participant's Overview
  • 9.17.2. Financial Performance
  • 9.17.3. Product Benchmarking
  • 9.17.4. Recent Developments/ Strategic Initiatives
• 9.18. Boditech Med, Inc.
  • 9.18.1. Participant's Overview
  • 9.18.2. Financial Performance
  • 9.18.3. Product Benchmarking
  • 9.18.4. Recent Developments/ Strategic Initiatives
• 9.19. Aidian
  • 9.19.1. Participant's Overview
  • 9.19.2. Financial Performance
  • 9.19.3. Product Benchmarking
  • 9.19.4. Recent Developments/ Strategic Initiatives